David Morris
Follow
Get notifications in MyBN when activity occurs.
David Morris
Chief Strategy Officer, Regional President for Asia Pacific / Nanosonics
David Morris has more than 25 years of leadership, international business development and strategy experience. He also has extensive experience internationally and domestically in the healthcare, consumer products, utilities and financial services industries.
Mr Morris was chief executive and managing director of the Monash IVF Group, chief strategy officer of Cochlear, president of Cochlear Bone Anchored Solutions, and at Accenture in the strategy practice.
He holds degrees in Business and Applied Science from Monash University, completed an Advanced Business Management Program at Kellogg School of Management at Northwestern University, and is a graduate of the Australian Institute of Company Directors.
Mr Morris was chief executive and managing director of the Monash IVF Group, chief strategy officer of Cochlear, president of Cochlear Bone Anchored Solutions, and at Accenture in the strategy practice.
He holds degrees in Business and Applied Science from Monash University, completed an Advanced Business Management Program at Kellogg School of Management at Northwestern University, and is a graduate of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1064th | Nanosonics | -14% | -14% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Nanosonics | $171.8m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Chief Strategy Officer, Regional President for Asia Pacific, Nanosonics | 24 Nov 2020 |
